Company intelligence / Profile preview

Shilpa Biologicals

Dharwad, Karnataka, Indiashilpabio.com ↗
Ownership
Private
Development stage
Commercial
01

Overview

Shilpa Biologicals has completed Phase III trials for its adalimumab biosimilar and is entering Phase III with an aflibercept biosimilar. The company has a recombinant human albumin program in Phase III trials. It is also developing a novel immune checkpoint inhibitor in partnership with mAbTree Biologics at the proof-of-concept stage. The company offers full-service CDMO capabilities and recently opened a dedicated ADC development suite[7][8][4].

Therapeutic areas
OncologyOphthalmologyImmunology
Modalities
Monoclonal antibodies (mAbs)Fusion proteins (FC fusion protein)Recombinant proteins (e.g., recombinant human albumin)BiosimilarsAntibody-drug conjugates (ADCs)
Industry
Biotech
02

Drug pipeline

4 assets

SBM-04

Preclinical

3 more assets in the full pipeline.

Request access →
03

Partnerships

mAbTree Biologics AG – co-development of novel immuno-oncology asset/checkpoint inhibitor [7]

Beyond the preview

Go deeper on Shilpa Biologicals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shilpa Biologicals.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call